Disclosure of interest: All authors: Nothing to disclose E-Posters - DIAGNOSIS / ETIOLOGY 04.00 - DIAGNOSIS / ETIOLOGY - 04.01 - DIAGNOSIS/INVESTIGATION OF STROKE ETIOLOGY P2354 - ESOC25-772 UTILITY OF PRO-ADRENOMEDULLIN DETERMINATION IN THE STROKE CODE: PRESTO STUDY Cristina Sanabria Gago 1 , Raquel Berbegal Serralta 1 , Jaime Alonso 1 , Vanesa Escribano 2 , Beln Colino Galian 2 , Elena Salgado Barbado 2 , Mnica Sobrado Sanz 3 , Carmen Ramos 1 , Alvaro Ximnez-Carrillo 1 , Elisa de la Fuente Sanz 1 , Alicia Gonzalez-Martinez 1 , Carmen Snchez-Rodrguez 1 , Alba Somovilla 1 , Jose Vivancos 1 , Santiago Trillo Senin 1 1 Neurology Department
Learn the benefits, risks, and how to manage side effects
& Elli, E
[DOI] [PMC free article] [PubMed] [Google Scholar] 43.Jeffers A.M., Glantz S., Byers A.L., Keyhani S
Other prescribed non-GLP-1 oral antihyperglycemic medications included sulfonylureas (21.5%), dipeptidyl peptidase 4 (DPP4) inhibitors (9.6%), SGLT2 inhibitors (41.6%), and thiazolidinediones (7.8%)
Always wait at least 48 hours between injections
